BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26096756)

  • 1. [Agranulocytosis related to fluindione: A case report].
    Ngo S; Benhamou Y; Armengol G; Sauvêtre G; Cailleux-Talbot N; Massy N; Buchonnet G; Lévesque H
    Rev Med Interne; 2016 Jan; 37(1):58-61. PubMed ID: 26096756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoallergic adverse effects of fluindione.
    Prescrire Int; 2010 Nov; 19(110):255-6. PubMed ID: 21284358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute immuno-allergic interstitial nephritis caused by fluindione.
    Belmouaz S; Desport E; Abou Ayache R; Thierry A; Mignot A; Bauwens M; Goujon JM; Bridoux F; Touchard G
    Clin Nephrol; 2006 Dec; 66(6):455-8. PubMed ID: 17176918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute immuno-allergic interstitial nephritis after treatment with fluindione. Seven cases].
    Reynaud F; Giraud P; Cisterne JM; Verdier D; Kouchakipour Z; Hermelin A; Modesto-Segonds A; Bagheri H; Pourrat J
    Nephrol Ther; 2009 Jul; 5(4):292-8. PubMed ID: 19357010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypersensitivity to fluindione (Previscan). Positive skin patch tests].
    Frouin E; Roth B; Grange A; Grange F; Tortel MC; Guillaume JC
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 1):1000-2. PubMed ID: 16446646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic nephropathy induced by fluindione must be addressed.
    Cam G; Kwetcheu AT; Vigneau C; Siohan P; Queffeulou G; Gatault P; Laruelle E; Crémault A; Le Cacheux P; Rioux-Leclercq N; Renaudineau E
    Nephrol Dial Transplant; 2012 Apr; 27(4):1554-8. PubMed ID: 21931126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fluindione-induced acute exanthematous pustulosis with renal involvement].
    Thurot C; Reymond JL; Bourrain JL; Pinel N; Beani JC
    Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1146-9. PubMed ID: 14724519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asymptomatic acute cytolytic hepatitis due to fluindione and associated with resistance to treatment: a case report and review of the literature].
    Penot JP; Fontenelle P; Dorleac D
    Arch Mal Coeur Vaiss; 1998 Feb; 91(2):267-70. PubMed ID: 9749256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluindione and drug reaction with eosinophilia and systemic symptoms: an unrecognised adverse effect?
    Daveluy A; Milpied B; Barbaud A; Lebrun-Vignes B; Gouraud A; Laroche ML; Ciobanu E; Bégaud B; Moore N; Miremont-Salamé G; Haramburu F;
    Eur J Clin Pharmacol; 2012 Jan; 68(1):101-5. PubMed ID: 21792562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug hypersensitive syndrome caused by fluindione].
    Sparsa A; Bédane C; Benazahary H; De Vencay P; Gauthier ML; Le Brun V; Boulinguez S; Loustaud-Ratti V; Soria P; Vidal E; Bonnetblanc JM
    Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1014-8. PubMed ID: 11907960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute interstitial nephritis of fluindione: about three cases].
    Beauchamp C; Enache I; Haskour A; Martin L
    Nephrol Ther; 2008 Oct; 4(5):339-46. PubMed ID: 18417438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluindione-induced acute generalised exanthematous pustulosis confirmed by patch testing].
    Chtioui M; Cousin-Testard F; Zimmermann U; Amar A; Saiag P; Mahé E
    Ann Dermatol Venereol; 2008 Apr; 135(4):295-8. PubMed ID: 18420077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Divisibility of warfarin and fluindione tablets tested in elderly patients and their family circle].
    Pautas E; Despres J; Peyron I; Golmard JL; Grange J; Koenig N; Gouronnec A; Mitha N; Siguret V; Gouin-Thibault I
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):171-7. PubMed ID: 21690025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytolytic hepatitis of immuno-allergic mechanism caused by fluindione].
    Andant C; Aguettant L; Soule JC
    Gastroenterol Clin Biol; 1997; 21(3):237-8. PubMed ID: 9161507
    [No Abstract]   [Full Text] [Related]  

  • 15. [Relationship between maintenance dosages of fluindione (Préviscan) and warfarin (Coumadin) for patients 70 years and older].
    Pautas É; Peyron I; Gouin-Thibault I; Gouronnec A; Monti A; Bouhadiba S; Badie C; Golmard JL; Siguret V
    Rev Med Interne; 2015 Jan; 36(1):7-9. PubMed ID: 24373728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent pyoderma gangrenosum-like ulcers induced by oral anticoagulants].
    Pralong P; Debarbieux S; Paret N; Balme B; Depaepe L; Nosbaum A; Ben-Said B; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2014 Jan; 141(1):34-8. PubMed ID: 24461092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is fluindione hepatotoxic?].
    Biour M; Davy JM; Poynard T; Lévy VG
    Gastroenterol Clin Biol; 1990; 14(10):782. PubMed ID: 2262128
    [No Abstract]   [Full Text] [Related]  

  • 18. [The interaction of oxaceprol and fluindione].
    Bannwarth B; Tréchot P; Mathieu J; Froment J; Netter P
    Therapie; 1990; 45(2):162-3. PubMed ID: 2353333
    [No Abstract]   [Full Text] [Related]  

  • 19. Unexpected Problems of Antithrombotic Therapy with An Unusual Side Effect of Vitamin K Antagonists after Mitral Valve Replacement.
    Marchandot B; Messas N; Jesel L; Trinh A; Kibler M; Reydel A; Ohlmann P; Morel O
    J Heart Valve Dis; 2017 May; 26(3):309-313. PubMed ID: 29092116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garlic interaction with fluindione: a case report.
    Pathak A; Léger P; Bagheri H; Senard JM; Boccalon H; Montastruc JL
    Therapie; 2003; 58(4):380-1. PubMed ID: 14679681
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.